secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-08-18T20:27:36+00:00
Accession:  0001193125-26-355550
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics adjourns special meeting again; needs 75% vote for governance change
--------------------------------------------------------------------------------

- Special meeting reconvened Aug 17, 2026, adjourned again due to insufficient votes for proposal.
- Quorum present: 10,601,849 shares (71.6% of 14,806,997 outstanding as of May 28, 2026 record date).
- Proposal: replace supermajority voting requirements and permit stockholder action by written consent; requires 75% affirmative vote.
- Meeting reconvenes Sept 15, 2026 at 12:00 p.m. ET via webcast; record date unchanged.
- Proxies previously submitted will be voted unless revoked; no changes to proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/0001193125-26-355550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/d919907d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-355550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer